Works matching IS 14787547 AND DT 2023 AND VI 21
Results: 98
Cost-utility analysis of genomic profiling in early breast cancer in Colombia.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00449-5
- By:
- Publication type:
- Article
Impact of a diabetes pay-for-performance program on nonincentivized mental disorders: a panel study based on claims database analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00450-y
- By:
- Publication type:
- Article
A cost-effectiveness analysis of COVID-19 critical care interventions in Addis Ababa, Ethiopia: a modeling study.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00446-8
- By:
- Publication type:
- Article
Could high continuity of care (COC) have a negative impact on subjective health of hypertensive patients? A Japanese perspective.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00448-6
- By:
- Publication type:
- Article
Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00447-7
- By:
- Publication type:
- Article
Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00442-y
- By:
- Publication type:
- Article
Budget impact analysis of a digital monitoring platform for COPD.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00443-x
- By:
- Publication type:
- Article
A cost-effectiveness analysis of ruxolitinib versus best alternative therapy for patients with steroid-refractory chronic graft-versus-host disease aged > 12 years in Singapore.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00444-w
- By:
- Publication type:
- Article
Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Cost of image-guided percutaneous nephrostomy among cervical cancer patients at Muhimbili National Hospital in Tanzania.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00445-9
- By:
- Publication type:
- Article
Assessment of equity and efficiency of magnetic resonance imaging services in Henan Province, China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00440-0
- By:
- Publication type:
- Article
What are economic costs and when should they be used in health economic studies?
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00436-w
- By:
- Publication type:
- Article
The FLURESP European commission project: cost-effectiveness assessment of ten public health measures against influenza in Italy: is there an interest in COVID-19 pandemic?
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00432-0
- By:
- Publication type:
- Article
Health and economic outcomes of a universal early intervention for parents and children from birth to age five: evaluation of the Salut Programme using a natural experiment.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00439-7
- By:
- Publication type:
- Article
Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00438-8
- By:
- Publication type:
- Article
Systematic review of economic evaluations for paediatric pulmonary diseases.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00423-1
- By:
- Publication type:
- Article
Healthcare reform and productivity of Hospital: a DEA-based analysis from South West of Iran.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-022-00403-x
- By:
- Publication type:
- Article
Associations between treatment burden, self-reported treatment qualities, antiretroviral therapy obtainment, and health-related quality of life among Ugandan PLWH.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00434-y
- By:
- Publication type:
- Article
Correction to: Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00433-z
- By:
- Publication type:
- Article
Monetary valuation of COVID-19 informal care: caregivers' willingness to pay and willingness to accept.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00437-9
- By:
- Publication type:
- Article
Cost-effectiveness of COVID-19 vaccination in Latin America and the Caribbean: an analysis in Argentina, Brazil, Chile, Colombia, Costa Rica, Mexico, and Peru.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00430-2
- By:
- Publication type:
- Article
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00435-x
- By:
- Publication type:
- Article
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00429-9
- By:
- Publication type:
- Article
Excess healthcare costs of mental disorders in children, adolescents and young adults in the Basque population registry adjusted for socioeconomic status and sex.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00428-w
- By:
- Publication type:
- Article
COVID-19 versus applied infection control policies in a Major Transplant Center in Iran.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00427-x
- By:
- Publication type:
- Article
Cost-effectiveness analysis of coronary arteries bypass grafting (CABG) and percutaneous coronary intervention (PCI) through drug stent in iran: a comparative study.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00426-y
- By:
- Publication type:
- Article
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00425-z
- By:
- Publication type:
- Article
Economic costs, health-related quality of life outcomes and cost-utility of a physical and psychological group intervention targeted at older adults with neurogenic claudication.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-022-00410-y
- By:
- Publication type:
- Article
Cost effectiveness of home care versus hospital care: a retrospective analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00424-0
- By:
- Publication type:
- Article
Cost-effectiveness of seven-days-per-week rehabilitation schedule for acute stroke patients.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00421-3
- By:
- Publication type:
- Article
Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00422-2
- By:
- Publication type:
- Article
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00420-4
- By:
- Publication type:
- Article
Correction: One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-022-00411-x
- By:
- Publication type:
- Article
Use of real-world evidence to support regulatory decisions on medical devices in China and a unique opportunity to gain accelerated approval in "Boao Lecheng Pilot Zone".
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-022-00412-w
- By:
- Publication type:
- Article
One-stage vs two-stage bilateral THA in Lombardy: a cost-effectiveness analysis.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00418-y
- By:
- Publication type:
- Article
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00417-z
- By:
- Publication type:
- Article
Direct and indirect medical costs of bladder cancer in Iran.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00416-0
- By:
- Publication type:
- Article
Systematic review of economic evaluations on stereotactic ablative radiotherapy (SABR) compared to other radiotherapy techniques or surgical procedures for early-stage non-small cell lung cancer.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00415-1
- By:
- Publication type:
- Article
Quantifying the direct cost benefits of vestibular telemetry using the CAVA system to diagnose the causes of dizziness.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-022-00413-9
- By:
- Publication type:
- Article
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00414-2
- By:
- Publication type:
- Article
Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00501-4
- By:
- Publication type:
- Article
Population ageing and sustainability of healthcare financing in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00505-0
- By:
- Publication type:
- Article
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00500-5
- By:
- Publication type:
- Article
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00504-1
- By:
- Publication type:
- Article
Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00502-3
- By:
- Publication type:
- Article
A systematic literature review on direct and indirect costs of triple-negative breast cancer.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00503-2
- By:
- Publication type:
- Article
Cost-effectiveness of abemaciclib plus endocrine therapy in high-risk HR+/HER2–early breast cancer in China.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00499-9
- By:
- Publication type:
- Article
Health system productivity in sub-Saharan Africa: tuberculosis control in high burden countries.
- Published in:
- Cost Effectiveness & Resource Allocation, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12962-023-00485-1
- By:
- Publication type:
- Article